Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Actelion Ltd    ATLN   CH0010532478

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Actelion Ltd
Develops, produces and markets pharmaceutical drugs

Actelion Ltd. operates as a holding company with interests in developing, producing and marketing pharmaceutical drugs.

It is a biopharmaceutical company, which focuses on the drug discovery, development, registration, production and commercialization of innovative drugs for diseases with significant unmet medical needs.

Its portfolio of PAH treatments covers the spectrum of disease, from WHO Functional Class (FC) II through to FC IV, with oral, inhaled and intravenous medications.

It has treatments for specialist diseases, including Type 1 Gaucher disease, Niemann-Pick type C disease, digital ulcers in patients suffering from systemic sclerosis and mycosis fungoides in patients with cutaneous T-cell lymphoma.

The company products include Tracleer (bosentan), Zavesca (miglustat), Ventavis (iloprost), Veletri (epoprostenol for injection), Valchlor and Opsumit (macitentan).

The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Mueller, and Thomas Widmann on December 17, 1997 and is headquartered in Allschwil, Switzerland.
Sales per Businesses
20142015Delta
CHF (in Million)%CHF (in Million)%
Drugs1,958100%2,045100% +4.45%
Sales per Regions
20142015Delta
CHF (in Million)%CHF (in Million)%
United States879.2444.9%1,02650.1% +16.64%
Europe687.8235.1%633.2031% -7.94%
Other360.5218.4%167.868.2% -53.44%
Switzerland30.301.5%28.391.4% -6.32%
Japan--190.069.3%-
Managers
NameAgeSinceTitle
Jean-Paul Clozel611997Chief Executive Officer & Executive Director
Jean-Pierre Garnier682011Chairman
Otto Schwarz612008Chief Operating Officer & Executive Vice President
André C. Muller, MBA532013Chief Financial Officer & Executive Vice President
Martine Clozel, MD611997Chief Scientific Officer & Senior Vice President
Michael Jacobi, PhD632009Independent Non-Executive Director
Jean Pierre Malo CFA, MBA622004Independent Non-Executive Director
Juhani Anttila62-Independent Non-Executive Director
Robert J. Bertolini, CPA53-Independent Non-Executive Director
Peter Gruss, PhD672012Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 107,761,427 89,519,496 83.1% 4,103,000 3.8% 83.1%
Shareholders
NameEquities%
Rudolf Maag, MBA 5,467,305 5.07%
Jean-Paul Clozel 5,418,507 5.03%
Actelion Ltd. 3,257,940 3.02%
UBS AG (Investment Management) 2,274,277 2.11%
Artisan Partners LP 2,013,026 1.87%
Fidelity Management & Research Co. 2,010,921 1.87%
The Vanguard Group, Inc. 1,870,256 1.74%
Bellevue Asset Management AG 1,702,164 1.58%
BlackRock Investment Management (UK) Ltd. 1,655,826 1.54%
Credit Suisse AG 1,526,933 1.42%
Holdings
NameEquities%Valuation
Actelion Ltd (ATLN) 3,257,9403.02%471,114,805 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
ACTELION LTD40.40%21 739
AMGEN, INC.-11.29%107 132
GILEAD SCIENCES, INC.-28.02%95 410
CELGENE CORPORATION-1.78%91 187
REGENERON PHARMACEUTIC..-31.34%39 310
VERTEX PHARMACEUTICALS..-38.15%18 727
GENMAB A/S32.53%10 179
TESARO INC154.89%7 122
EXELIXIS, INC.192.91%4 976
HUALAN BIOLOGICAL ENGI..--.--%4 715
TONGHUA DONGBAO PHARMA..-83.11%4 669
NEUROCRINE BIOSCIENCES..-23.58%3 755
CHINA BIOLOGIC PRODUCT..-19.42%3 115
ULTRAGENYX PHARMACEUTI..-33.54%3 046
BEIJING SL PHARMACEUTI..--.--%2 925
GW PHARMACEUTICALS PLC85.37%2 829
PEPTIDREAM INC40.33%2 753
BIOCON LTD76.28%2 687
BLUEBIRD BIO INC8.61%2 602
ARIAD PHARMACEUTICALS,..109.12%2 556
KITE PHARMA INC-17.69%2 532
Sector Bio Therapeutic Drugs
Actelion Ltd : Connections
16 Gewerbestrasse
CH-4123 Allschwil, Basel-Landschaft
Switzerland

Phone : +41 61 565 65 65
Fax : +41 61 565 65 00
Internet : http://www.actelion.com
Markets and indexes
- SIX Swiss Exchange
- Main Standard
- SMI /
Stock Exchange Codes
- ISIN Code :  CH0010532478
- Bloomberg Code :  ATLN:VX
- Reuters Code :  ATLN.VX
- Datastream Code :  S:ATLN
© 2016 People , Fundamentals and Ownership    © 2016 Cofisem